Blau Farmacêutica S.A. (BVMF:BLAU3)

Brazil flag Brazil · Delayed Price · Currency is BRL
10.11
-0.32 (-3.07%)
Mar 9, 2026, 4:15 PM GMT-3
4.31%
Market Cap 2.41B
Revenue (ttm) 1.77B
Net Income (ttm) 324.56M
Shares Out 230.99M
EPS (ttm) 1.40
PE Ratio 7.44
Forward PE 8.12
Dividend 0.36 (3.40%)
Ex-Dividend Date Dec 19, 2025
Volume 214,700
Average Volume 543,460
Open 10.41
Previous Close 10.43
Day's Range 10.08 - 10.41
52-Week Range 8.72 - 11.58
Beta 0.39
RSI 44.84
Earnings Date Mar 18, 2026

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics... [Read more]

Sector Healthcare
Founded 1987
Employees 1,900
Stock Exchange Brazil Stock Exchange
Ticker Symbol BLAU3
Full Company Profile

Financial Performance

In 2024, Blau Farmacêutica's revenue was 1.75 billion, an increase of 27.81% compared to the previous year's 1.37 billion. Earnings were 217.21 million, a decrease of -13.05%.

Financial Statements

News

There is no news available yet.